Targeting BRAF in metastatic colorectal cancer: Maximizing molecular approaches - ScienceDirect
BRAF Mutation in Colorectal Cancer | IntechOpen
Glimmers of Hope—New Strategies for Overcoming Treatment Resistance in Patients with BRAF V600E-mutated Metastatic Colorectal Cancer - touchONCOLOGY
Cancers | Free Full-Text | Conversion Strategy in Left-Sided RAS/BRAF Wild- Type Metastatic Colorectal Cancer Patients with Unresectable Liver-Limited Disease: A Multicenter Cohort Study
Targeted Therapy for Colorectal Cancers With Non-V600 BRAF Mutations: Perspectives for Precision Oncology | JCO Precision Oncology
Targeted Drug Trio for Colorectal Cancer with BRAF Mutations - NCI
BRAFV600E immunohistochemistry in conjunction with mismatch repair status predicts survival in patients with colorectal cancer | Modern Pathology
Frontiers | Current Therapeutic Strategies in BRAF-Mutant Metastatic Colorectal Cancer
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
Colorectal Cancer – Treatments | Gastrointestinal Cancer
Diabetes mellitus in relation to colorectal tumor molecular subtypes: A pooled analysis of more than 9000 cases - Harlid - 2022 - International Journal of Cancer - Wiley Online Library
Management of BRAF-mutant metastatic colorectal cancer: a review of treatment options and evidence-based guidelines - Annals of Oncology
Frontiers | Management of BRAF Gene Alterations in Metastatic Colorectal Cancer: From Current Therapeutic Strategies to Future Perspectives
Cells | Free Full-Text | KRAS and BRAF Mutations as Prognostic and Predictive Biomarkers for Standard Chemotherapy Response in Metastatic Colorectal Cancer: A Single Institutional Study
Overview of molecular biomarkers in metastatic colorectal cancer. WT,... | Download Scientific Diagram
Therapeutic strategy in unresectable metastatic colorectal cancer: an updated review - Benoist Chibaudel, Christophe Tournigand, Franck Bonnetain, Hubert Richa, Magdalena Benetkiewicz, Thierry André, Aimery de Gramont, 2015
Personalized Medicine in Oncology - <em>BRAF</em> Mutation in Colorectal Cancer<br> <h4>Anita Turk, MD; Dustin Deming, MD<br>Division of Hematology and Oncology,Department of Medicine<br>University of Wisconsin-Madison School of Medicine and Public ...
RNF43 mutations predict response to anti-BRAF/EGFR combinatory therapies in BRAFV600E metastatic colorectal cancer | Nature Medicine
KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness | OTT
Targeting the Tumor in Colorectal Cancer – Where do we Stand with Precision Medicine in 2020 | Published in healthbook TIMES Oncology Hematology
Evolving Strategies for the Management of BRAF-Mutant Metastatic Colorectal Cancer
Cureus | Incidence of BRAF V600E Gene Mutation Among Lebanese Population in Melanoma and Colorectal Cancer: A Retrospective Study Between 2010 and 2019 | Article
Kaplan-Meier curves for colorectal cancer patients with BRAF-wild-type... | Download Scientific Diagram
